Wegovy is a powerful weight loss medication. As a GLP-1 receptor agonist, it imitates the actions of a natural hormone, GLP-1, influencing appetite control and metabolism. By activating GLP-1 receptors, Semaglutide helps people feel full, reducing food intake, and promotes weight loss by enhancing the body's utilisation of calories.  Administered through injections, Semaglutide for weight loss is often prescribed as part of a comprehensive approach that includes a balanced diet and regular physical activity.

Important Notice About Starting Wegovy
If you are a new patient, or this is your first time using Wegovy, you must begin with Month 1 (0.25mg).

Wegovy is a step-up medication designed to be introduced gradually. 

Even if you’re eager to begin seeing results, the first month is essential to help your body adjust to the medication properly. Skipping this step is not an option, it is a medical requirement.

Prescription-Only Medication Notice:
This peptide is a Schedule 4 prescription-only treatment. Selecting this product does not guarantee access or approval. All patients must undergo a consultation with an AHPRA-registered medical practitioner, who will assess clinical suitability and determine whether this treatment is appropriate. Prescriptions are issued only when medically justified and in line with regulatory guidelines.

**All peptide therapies available through PHYX require a medical consultation and prescription. Treatment suitability is determined by an AHPRA-registered clinician.**